BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 10029292)

  • 21. Diagnostic efficacy of tests for the detection of iron overload in chronic liver disease.
    Valberg LS; Ghent CN; Lloyd DA; Frei JV; Chamberlain MJ
    Can Med Assoc J; 1978 Aug; 119(3):229-36. PubMed ID: 679127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum ferritin concentrations in Africans with low dietary iron.
    Moyo VM; Mvundura E; Khumalo H; Gangaidzo IT; Saungweme T; Nouraie M; Rouault TA; Gomo ZA; Gordeuk VR
    Ann Hematol; 2009 Nov; 88(11):1131-6. PubMed ID: 19259672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia Patients.
    Koonrungsesomboon N; Tantiworawit A; Phrommintikul A; Saekho S; Srichairattanakool S; Chattipakorn N
    Hemoglobin; 2015; 39(4):281-6. PubMed ID: 26029793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basal endocrine status in African dietary iron overload.
    McNamara L; Panz VR; Raal FJ; Paiker J; Joffe BI; Gordeuk VR; MacPhail AP
    Endocrine; 2003 Aug; 21(3):241-4. PubMed ID: 14515008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
    Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
    Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytical evaluation of serum non-transferrin-bound iron and its relationships with oxidative stress and cardiac load in the general population.
    Sugiura T; Dohi Y; Takase H; Fujii S; Seo Y; Ohte N
    Medicine (Baltimore); 2021 Feb; 100(7):e24722. PubMed ID: 33607814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating iron overload in patients with suspected liver disease and elevated serum ferritin.
    Cippà PE; Boucsein I; Adams H; Krayenbuehl PA
    Am J Med; 2014 Oct; 127(10):1011.e1-3. PubMed ID: 24662623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron metabolism in kidney allograft recipients: still a mystery?
    Malyszko J; Głowińska I; Malyszko JS; Levin-Iaina N; Koc-Zorawska E; Mysliwiec M
    Transplant Proc; 2011 Oct; 43(8):2973-5. PubMed ID: 21996204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
    Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
    Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of iron status in lemurs by analysis of serum iron and ferritin concentrations, total iron-binding capacity, and transferrin saturation.
    Williams CV; Junge RE; Stalis IH
    J Am Vet Med Assoc; 2008 Feb; 232(4):578-85. PubMed ID: 18279098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
    Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
    J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1.
    al-Refaie FN; Wickens DG; Wonke B; Kontoghiorghes GJ; Hoffbrand AV
    Br J Haematol; 1992 Oct; 82(2):431-6. PubMed ID: 1419825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common presence of non-transferrin-bound iron among patients with type 2 diabetes.
    Lee DH; Liu DY; Jacobs DR; Shin HR; Song K; Lee IK; Kim B; Hider RC
    Diabetes Care; 2006 May; 29(5):1090-5. PubMed ID: 16644642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine.
    Ambrus CM; Stadler I; Toumbis CA; Stadler A; Anthone S; Anthone R; DeAlarcon P; Deshpande G; Conway J; Vladutiu AO; Ambrus JL
    J Med; 1999; 30(3-4):211-24. PubMed ID: 17312675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Two novel potential markers for iron metabolism: hepcidin and non-transferrin-bound iron (NTBI)].
    Ikuta K
    Rinsho Ketsueki; 2015 Feb; 56(2):194-203. PubMed ID: 25765800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.
    Gosriwatana I; Loreal O; Lu S; Brissot P; Porter J; Hider RC
    Anal Biochem; 1999 Sep; 273(2):212-20. PubMed ID: 10469492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma non-transferrin-bound iron uptake by the small intestine leads to intestinal injury and intestinal flora dysbiosis in an iron overload mouse model and Caco-2 cells.
    Zhang Q; Ding H; Yu X; Wang Q; Li X; Zhang R; Feng J
    Sci China Life Sci; 2023 Sep; 66(9):2041-2055. PubMed ID: 37452897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.